This topic contains a solution. Click here to go to the answer

Author Question: In patients with chronic renal failure, inadequate production of the hormone erythropoietin causes ... (Read 63 times)

drink

  • Hero Member
  • *****
  • Posts: 554
In patients with chronic renal failure, inadequate production of the hormone erythropoietin causes
 
  a. anemia.
  b. uremia.
  c. hypertension.
  d. fluid retention.

Question 2

Patients with chronic renal failure often need supplements that contain an active form of vitamin
 
  a. A.
  b. C.
  c. D.
  d. K.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lorealeza

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

A
Erythropoietin stimulates bone marrow to produce red blood cells, so inadequate production in patients with chronic renal failure causes anemia. Uremia is caused by accumulation of nitro-genous waste products. Hypertension is caused by inadequate renin production. Fluid retention is caused by failure to produce urine and by sodium retention.

Answer to Question 2

C
Patients with chronic renal failure often need supplements that contain an active form of vitamin D because the kidney fails to complete the final step in activating vitamin D. Supplements of fat-soluble vitamins (including A and K) are not needed; vitamin A toxicity has sometimes de-veloped in hemodialysis patients. Supplements of vitamin C and other water-soluble vitamins may be needed but do not need to be given in an active form.




drink

  • Member
  • Posts: 554
Reply 2 on: Aug 2, 2018
Wow, this really help


shailee

  • Member
  • Posts: 392
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

Tobacco depletes the body of vitamins A, C, and E, which can result in any of the following: dry hair, dry skin, dry eyes, poor growth, night blindness, abscesses, insomnia, fatigue, reproductive system problems, sinusitis, pneumonia, frequent respiratory problems, skin disorders, weight loss, rickets, osteomalacia, nervousness, muscle spasms, leg cramps, extremity numbness, bone malformations, decayed teeth, difficulty in walking, irritability, restlessness, profuse sweating, increased uric acid (gout), joint damage, damaged red blood cells, destruction of nerves, infertility, miscarriage, and many types of cancer.

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library